Testopel
Endo buys Auxilium for $2.6 billion
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum
Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
